Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $15,615 | $10,114 | $0 | $39 |
| % Growth | 54.4% | – | -100% | – |
| Cost of Goods Sold | $1,063 | $1,792 | $3 | $42 |
| Gross Profit | $14,552 | $8,322 | -$3 | -$3 |
| % Margin | 93.2% | 82.3% | – | -7.7% |
| R&D Expenses | $5,424 | $8,669 | $13,335 | $16,007 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $13,998 | $11,298 | $8,263 | $9,385 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,422 | $19,967 | $21,598 | $25,392 |
| Operating Income | -$4,870 | -$11,645 | -$21,598 | -$25,392 |
| % Margin | -31.2% | -115.1% | – | -65,107.7% |
| Other Income/Exp. Net | $136 | -$84 | -$315 | -$3,640 |
| Pre-Tax Income | -$5,006 | -$11,729 | -$21,913 | -$29,032 |
| Tax Expense | $137 | -$2,790 | $16 | $13 |
| Net Income | -$5,143 | -$8,939 | -$21,929 | -$29,045 |
| % Margin | -32.9% | -88.4% | – | -74,474.4% |
| EPS | -0.026 | -0.049 | -0.12 | -0.17 |
| % Growth | 47.7% | 59.3% | 29.4% | – |
| EPS Diluted | -0.026 | -0.049 | -0.12 | -0.17 |
| Weighted Avg Shares Out | 201,918 | 183,237 | 188,358 | 175,567 |
| Weighted Avg Shares Out Dil | 201,918 | 183,237 | 188,358 | 175,567 |
| Supplemental Information | – | – | – | – |
| Interest Income | $559 | $615 | $128 | $117 |
| Interest Expense | $943 | $901 | $128 | $117 |
| Depreciation & Amortization | $807 | $817 | $53 | $74 |
| EBITDA | -$4,063 | -$10,828 | -$21,732 | -$28,841 |
| % Margin | -26% | -107.1% | – | -73,951.3% |